Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Bejar

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
Blood Neoplasia|June 2, 2025
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS StudyAmy E DeZern, Johannes B Goll, Travis L Jensen, et al.
Blood Advances|August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapiesEdward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.
Blood Advances|March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditionsAmy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Ejhaem|July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease RegistryDaniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Leukemia & Lymphoma|May 22, 2019
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromesMikkael A Sekeres, Steven D Gore, Donald M Stablein, et al.
American Journal of Hematology|March 30, 2026
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and SexNancy Gillis, Christelle Colin-Leitzinger, Yi-Han Tang, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
Blood Neoplasia|June 2, 2025
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS StudyAmy E DeZern, Johannes B Goll, Travis L Jensen, et al.
Blood Advances|August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapiesEdward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.
Blood Advances|March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditionsAmy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Ejhaem|July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease RegistryDaniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Leukemia & Lymphoma|May 22, 2019
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromesMikkael A Sekeres, Steven D Gore, Donald M Stablein, et al.
American Journal of Hematology|March 30, 2026
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and SexNancy Gillis, Christelle Colin-Leitzinger, Yi-Han Tang, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Blood Cancer Discovery|August 4, 2022
Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed SideroblastsVera Adema, Feiyang Ma, Rashmi Kanagal-Shamanna, et al.
Pageof 11